A total of two new applications were submitted for the 2025 Biotechnology Research Park Translational (BRPT) Project. Of these, one was selected for funding.
A total of two new applications were submitted for the 2025 Infectious Diseases Research (IDR) Project. Of these, two were selected for funding.
A total of 16 new applications were submitted for the 2025 Fundamental Investigation Inspired by Large-scale Biomedical Data (FILBD) Project. Of these, six were selected for funding. Please refer to the following lists for detailed information.
A - 2025 Academia Sinica ”Biotechnology Research Park Translational (BRPT) Project”
|
Project Title |
(1) Project PI (2) Project Co-PI |
Affiliation |
|
|
AS-BRPT-114-01 |
Targeting Novel LncRNA Myca-MYC Axis for Liver Cancer Therapy |
(1) Yu-Ru Lee (2) Wei-Chien Yuan (2) Hao-Jan Lei (2) Shih-Yu Chen (2) Che-Ming (Jack) Hu |
Institute of Biomedical Science, AS National Yang Ming Chiao Tung University Taipei Veterans General Hospital Institute of Biomedical Science, AS Institute of Biomedical Science, AS |
B - 2025 Academia Sinica“Infectious Diseases Research (IDR) Project”
|
Project No. |
Project Title |
(1) Project PI (2) Project Co-PI |
Affiliation |
|
AS-IDR-114-01 |
Therapeutic potential of de novo designed antimicrobial peptides against drug-resistant fungal infections |
(1) Rita P-Y Chen (2) Chi-Jung Wu (2) Tak-Wah Wong |
Institute of Biological Chemistry, AS National Health Research Institutes Department of Dermatology, NCKUH |
|
AS-IDR-114-02 |
Broad-Spectrum Bacteriophages for Antibiotic-Resistant Hospital-Acquired Infections |
(1) Todd L. Lowary (2) Meng-Chiao Ho (2) Chuan Ku (2) Li-Kuang Chen |
Institute of Biological Chemistry, AS Institute of Biological Chemistry, AS Institute of Plant and Microbial Biology, AS Tzu Chi University, Hualien, |
C - 2025 Academia Sinica “Fundamental Investigation Inspired by Large-scale Biomedical Data (FILBD) Project”
|
Project No. |
Project Title |
(1) Project PI (2) Project Co-PI |
Affiliation |
|
AS-FILBD-114-01 |
Applying large scale biomedical SNP data to study the underlying pathogenic mechanisms contributing to the syndesmophyte formation in patients with ankylosing spondylitis in Taiwan |
(1) Kuo-I Lin (2) Chin-Hsiu Liu (2) Hsin-Hua Chen (2) Ling-Hui Li (2) Tai-Ming Ko |
Genomics Research Center, AS National Taiwan University Hospital Taichung Veterans General Hospital Institute of Biomedical Science, AS National Yang Ming Chiao Tung University |
|
AS-FILBD-114-02 |
Leveraging Splicing Mutations for Precision Medicine: Insights from the Taiwan Precision Medicine Initiative |
(1) Chien-Ling Lin
(2) Yen-Tsung Huang |
Institute of Molecular Biology, AS
Institute of Statistical Science, AS |
|
AS-FILBD-114-03 |
Investigating Higher Order Genome Organization in Systemic Lupus Erythematosus with Integrated Genetic, Epigenetic, and Environmental Interactions |
(1) Shih-Yu Chen (2) Ying-Han Chen (2) Ling-Hui Li (2) Yi-Ming Chen (2) Tzu-Hung Hsiao (2) Hung-Hsin Chen |
Institute of Biomedical Science, AS Institute of Biomedical Science, AS Institute of Biomedical Science, AS Taichung Veterans General Hospital Taichung Veterans General Hospital Institute of Biomedical Science, AS |
|
AS-FILBD-114-04 |
Governance Frameworks and Clinical Applications of Genomic Data: Integration and Regulation |
(1) Chih-Hsing Ho (2) Jer-Yuarn Wu (2) Da-Wei Wang (2) Hsin-Chou Yang (2) Ling-Hui Li |
Institute of European and American Studies, AS Institute of Information Science, AS Institute of Statistical Science, AS Institute of Biomedical Science, AS |
|
AS-FILBD-114-05 |
Intelligence Utilization of Large-Scale Biomedical Data – Smart and Precision Health |
(1) Hsin-Chou Yang |
Institute of Statistical Science, AS |
|
AS-FILBD-114-06 |
Health Data Integration and Expansion: Insights from Taiwan Precision Medicine Initiative and Taiwan Biobank |
(1) Hung-Hsin Chen (2) Cathy SJ Fann (2) Chien-Hsiun Chen (2) Ming-Wei Su |
Institute of Biomedical Science, AS Institute of Biomedical Science, AS Institute of Biomedical Science, AS Biomedical Translation Research Center, AS |